Zdenĕk Šumnı́k

5.2k total citations · 1 hit paper
120 papers, 2.0k citations indexed

About

Zdenĕk Šumnı́k is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Zdenĕk Šumnı́k has authored 120 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Genetics, 61 papers in Endocrinology, Diabetes and Metabolism and 42 papers in Surgery. Recurrent topics in Zdenĕk Šumnı́k's work include Diabetes and associated disorders (52 papers), Diabetes Management and Research (42 papers) and Pancreatic function and diabetes (32 papers). Zdenĕk Šumnı́k is often cited by papers focused on Diabetes and associated disorders (52 papers), Diabetes Management and Research (42 papers) and Pancreatic function and diabetes (32 papers). Zdenĕk Šumnı́k collaborates with scholars based in Czechia, Germany and United Kingdom. Zdenĕk Šumnı́k's co-authors include Stanislava Koloušková, Ondřej Cinek, Jan Lebl, Lenka Petruželková, Barbora Obermannová, Štěpánka Průhová, Marta Šnajderová, Petra Dušátková, Štěpánka Průhová and J Vavřinec and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Immunology.

In The Last Decade

Zdenĕk Šumnı́k

105 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes

2023 111 citations Zdenĕk Šumnı́k, Agnieszka Szypowska et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zdenĕk Šumnı́k Czechia	26	1.2k	853	734	378	354	120	2.0k
Stanislava Koloušková Czechia	23	736 0.6×	531 0.6×	413 0.6×	337 0.9×	258 0.7×	83	1.3k
Paula Vähäsalo Finland	28	2.1k 1.8×	1.4k 1.6×	1.5k 2.1×	275 0.7×	520 1.5×	81	3.0k
Shoichiro Tanaka Japan	25	1.2k 1.0×	707 0.8×	928 1.3×	209 0.6×	282 0.8×	54	1.7k
Renato Zanchetta Italy	23	736 0.6×	1.2k 1.4×	345 0.5×	153 0.4×	247 0.7×	51	2.0k
M. Christy Denmark	14	1.4k 1.2×	962 1.1×	802 1.1×	142 0.4×	459 1.3×	30	1.9k
Pekka Ahonen Finland	10	521 0.4×	797 0.9×	199 0.3×	93 0.2×	246 0.7×	15	1.3k
Shinobu Ida Japan	19	224 0.2×	147 0.2×	454 0.6×	244 0.6×	94 0.3×	83	1.1k
David T. Robles United States	14	564 0.5×	367 0.4×	460 0.6×	70 0.2×	204 0.6×	21	1.1k
Tim Ulinski France	25	239 0.2×	213 0.2×	263 0.4×	426 1.1×	408 1.2×	93	1.9k
Anna Testa Italy	24	1.1k 0.9×	64 0.1×	576 0.8×	347 0.9×	95 0.3×	90	2.0k

Countries citing papers authored by Zdenĕk Šumnı́k

Since Specialization

Citations

This map shows the geographic impact of Zdenĕk Šumnı́k's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdenĕk Šumnı́k with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdenĕk Šumnı́k more than expected).

Fields of papers citing papers by Zdenĕk Šumnı́k

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zdenĕk Šumnı́k. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdenĕk Šumnı́k. The network helps show where Zdenĕk Šumnı́k may publish in the future.

Co-authorship network of co-authors of Zdenĕk Šumnı́k

This figure shows the co-authorship network connecting the top 25 collaborators of Zdenĕk Šumnı́k. A scholar is included among the top collaborators of Zdenĕk Šumnı́k based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdenĕk Šumnı́k. Zdenĕk Šumnı́k is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bonifacio, Ezio, Przemysława Jarosz‐Chobot, Mirjam Kohls, et al.. (2025). The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes. Diabetologia. 68(6). 1101–1107. 2 indexed citations

Plachý, Lukáš, Petra Dušátková, Vít Neuman, et al.. (2024). Monogenic causes of familial short stature. Frontiers in Endocrinology. 15. 1506323–1506323. 1 indexed citations

Formánek, Tomáš, Zdenĕk Šumnı́k, Karolína Mladá, et al.. (2024). Childhood-onset type 1 diabetes and subsequent adult psychiatric disorders: a nationwide cohort and genome-wide Mendelian randomization study. Nature Mental Health. 2(9). 1062–1070. 2 indexed citations

Plachý, Lukáš, Vít Neuman, Barbora Obermannová, et al.. (2024). Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study. Diabetes Research and Clinical Practice. 209. 111602–111602. 2 indexed citations

Zieg, Jakub, et al.. (2024). Hyperkalaemic acidosis: blood pressure is the diagnostic clue. Pediatric Nephrology. 40(4). 967–970.

Petruželková, Lenka, Jan Šoupal, Lukáš Plachý, et al.. (2021). Pre‐school and school‐aged children benefit from the switch from a sensor‐augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis. Pediatric Diabetes. 22(4). 594–604. 31 indexed citations

Šumnı́k, Zdenĕk, Markéta Pavlı́ková, Renata Pomahačová, et al.. (2021). Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry. Pediatric Diabetes. 22(3). 439–447. 15 indexed citations

Plachý, Lukáš, Petra Dušátková, Lenka Petruželková, et al.. (2021). Familial Short Stature—A Novel Phenotype of Growth Plate Collagenopathies. The Journal of Clinical Endocrinology & Metabolism. 106(6). 1742–1749. 21 indexed citations

Plachý, Lukáš, Petra Dušátková, Lenka Petruželková, et al.. (2020). NPR2 Variants Are Frequent among Children with Familiar Short Stature and Respond Well to Growth Hormone Therapy. The Journal of Clinical Endocrinology & Metabolism. 105(3). e746–e752. 30 indexed citations

10.

Cinek, Ondřej & Zdenĕk Šumnı́k. (2019). Type 1 diabetes: etiology and epidemiology. Vnitřní lékařství. 65(4). 235–247. 1 indexed citations

11.

Elblová, Lenka, Matthew B. Johnson, Petra Dušátková, et al.. (2019). Screening of monogenic autoimmune diabetes among children with type 1 diabetes and multiple autoimmune diseases: is it worth doing?. Journal of Pediatric Endocrinology and Metabolism. 32(10). 1147–1153. 6 indexed citations

12.

Neuman, Vít, Ondřej Cinek, David P. Funda, et al.. (2019). Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor. Diabetologia. 62(7). 1291–1296. 21 indexed citations

13.

Plachý, Lukáš, Lenka Elblová, Barbora Obermannová, et al.. (2019). High Prevalence of Growth Plate Gene Variants in Children With Familial Short Stature Treated With GH. The Journal of Clinical Endocrinology & Metabolism. 104(10). 4273–4281. 49 indexed citations

14.

Petruželková, Lenka, Jan Šoupal, Vít Neuman, et al.. (2018). Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity. Diabetes Technology & Therapeutics. 20(11). 744–750. 51 indexed citations

15.

Průhová, Štěpánka, Lenka Elblová, Matthew B. Johnson, et al.. (2018). Significant Prevalence of Severe Monogenic Immune Defects Among Children with Type 1 Diabetes and Low T1D-Genetic Risk Score. 1 indexed citations

16.

Šumnı́k, Zdenĕk & Štěpánka Průhová. (2016). LADY and MODY: How do we know them?. 13(1). 26–29.

17.

Šumnı́k, Zdenĕk, Ondřej Souček, & Jan Lebl. (2016). How to diagnose and treat hypophosphatasia. Pediatrie pro praxi. 17(3). 146–149. 1 indexed citations

18.

Koloušková, Stanislava, et al.. (2005). 308 Risk of diabetes in a cohort of 243 adults with cystic fibrosis. Journal of Cystic Fibrosis. 4. S81–S81. 1 indexed citations

19.

Šumnı́k, Zdenĕk, et al.. (2003). HLA-DQ Polymorphisms Modify the Risk of Thyroid Autoimmunity in Children with Type 1 Diabetes Mellitus. Journal of Pediatric Endocrinology and Metabolism. 16(6). 851–8. 19 indexed citations

20.

Cinek, Ondřej, Stanislava Koloušková, Marta Šnajderová, et al.. (2001). HLA class II genetic association of type 1 diabetes mellitus in Czech children. Pediatric Diabetes. 2(3). 98–102. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact